2m 2m 2m 2m 2m 2m 2m
Alkermes (ALKS)
NASDAQ
$48.36+$2.34 (+5.08%)
Price as of Jun 23, 2026 7:44 PM EDT- $7.6BMarket Cap
- 57.28%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alkermes (ALKS)
$48.36+$2.34 (+5.08%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.2B -23.95% | 1.6B -6.36% | 1.7B +49.61% | 1.1B -5.28% | |
Cost of Revenue | 196.5M -19.92% | 245.3M -3.05% | 253.0M +16.01% | 218.1M +10.50% | |
Gross Profit | 988.2M -24.70% | 1.3B -6.95% | 1.4B +57.81% | 893.7M -8.47% | |
Sales and Marketing Expense | 701.5M +8.72% | 645.2M -6.45% | 689.8M +13.87% | 605.7M +7.98% | |
Research and Development Expense | -324.0M +32.05% | -245.3M -9.41% | -270.8M -168.76% | 393.8M -3.12% | |
Depreciation and Amortization Expense | 27.2M -4.79% | 28.5M -61.92% | 74.9M -3.77% | 77.9M -1.00% | |
Total Operating Expenses | 1.2B +7.47% | 1.1B -8.99% | 1.2B -0.38% | 1.3B +4.24% | |
Operating Profit | 254.0M -39.63% | 420.6M +1.57% | 414.1M +391.09% | -142.3M +385.76% | |
Interest Income | 45.3M +6.72% | 42.5M +37.58% | 30.9M +304.43% | 7.6M +216.82% | |
Interest Expense | -12.3M N/A | N/A N/A | -23.0M +76.63% | -13.0M +16.23% | |
Interest Income and Expense and Net | 33.0M -22.25% | 42.5M +442.70% | 7.8M +2.53% | 7.6M +216.82% | |
Total Nonoperating Income and Expense | 37.5M +62.21% | 23.1M +212.48% | 7.4M +129.54% | -25.0M +149.92% | |
Income before Taxes | 291.4M -34.32% | 443.8M +5.27% | 421.5M +351.95% | -167.3M +325.64% | |
Income Taxes | 49.8M -30.48% | 71.6M +173.34% | -97.6M +980.42% | -9.0M -201.96% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 241.7M -34.16% | 367.1M +3.18% | 355.8M +324.78% | -158.3M +228.57% | |
Net Income from Continuing Operations Applicable to Common | 241.7M -35.06% | 372.1M -28.32% | 519.2M +410.31% | -167.3M +325.64% | |
Basic EPS and Net Income | 1.47 -33.78% | 2.22 +3.74% | 2.14 +320.62% | -0.97 +223.33% | |
Diluted EPS and Net Income | 1.43 -34.10% | 2.17 +3.33% | 2.10 +316.49% | -0.97 +223.33% | |
Basic Weighted Average Shares | 164.7M -0.42% | 165.4M -0.50% | 166.2M +1.64% | 163.5M +1.61% | |
Diluted Weighted Average Shares | 168.7M -0.27% | 169.2M -0.31% | 169.7M +3.78% | 163.5M +1.61% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 388.6M +33.46% | 291.1M -36.36% | 457.5M +56.41% | 292.5M -13.35% | |
Short-Term Investments | 199.6M -56.65% | 460.5M +45.72% | 316.0M +0.009% | 316.0M +58.98% | |
Cash and Cash Equivalents and Short-Term Investments | 588.2M -21.75% | 751.7M -2.82% | 773.5M +27.12% | 608.5M +13.45% | |
Total Current Assets | 1.9B +36.30% | 1.4B -4.72% | 1.5B +31.43% | 1.1B +6.41% | |
Accumulated Depreciation | 267.0M +5.53% | 253.0M +9.93% | 230.2M -46.93% | 433.7M +9.63% | |
Property and Plant and Equipment and Net | 221.7M -2.57% | 227.6M +0.27% | 226.9M -30.25% | 325.4M -4.60% | |
Total Long-Term Assets | 49.1M +197.52% | 16.5M +43.24% | 11.5M -21.58% | 14.7M +35.58% | |
Total Assets | 2.5B +20.99% | 2.1B -3.78% | 2.1B +8.77% | 2.0B -2.99% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 3.0M 0.00% | 3.0M 0.00% | 3.0M 0.00% | |
Total Current Liabilities | 543.4M +16.82% | 465.2M -10.58% | 520.2M +4.52% | 497.7M +5.61% | |
Total Long-Term Debt | N/A N/A | 287.7M 0.00% | 287.7M -0.88% | 290.3M -0.87% | |
Total Long-Term Liabilities | 61.0M +8.91% | 56.0M +12.31% | 49.9M +17.68% | 42.4M +31.80% | |
Total Liabilities | 667.7M +13.06% | 590.6M -36.74% | 933.5M +1.45% | 920.2M +0.91% | |
Retained Earnings | -734.8M -24.75% | -976.5M -27.32% | -1.3B -20.94% | -1.7B +10.27% | |
Total Stockholders Equity | 1.8B +24.19% | 1.5B +21.81% | 1.2B +15.23% | 1.0B -6.19% | |
Total Shares Outstanding | 165.6M +2.11% | 162.2M -2.88% | 167.0M +1.58% | 164.4M +1.51% | |
Cash Flow | |||||
Cash from Operating Activities | 520.8M +18.59% | 439.1M +9.41% | 401.4M +1,807.21% | 21.0M -79.31% | |
Capital Expenditures | 40.4M +20.71% | 33.5M -30.31% | 48.0M +25.60% | 38.3M +36.53% | |
Cash from Investing Activities | 295.5M +365.48% | -111.3M -308.61% | 53.4M +182.67% | -64.5M -2.51% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.4M +102.51% | -494.1M +70.56% | -289.7M +18,306.23% | -1.6M -105.41% | |
Financials Ratio | |||||
Gross Margin | 83.42% -0.99% | 84.25% -0.63% | 84.79% +5.48% | 80.38% -3.37% | |
Operating Margin | 21.44% -20.62% | 27.00% +8.47% | 24.90% +294.56% | -12.80% +412.82% | |
Return on Assets | 10.64% -39.25% | 17.51% +0.93% | 17.35% +318.66% | -7.94% +227.39% | |
Return on Equity | 14.72% -46.52% | 27.52% -13.11% | 31.67% +315.77% | -14.68% +232.10% | |
Revenue Growth | -23.95% +276.58% | -6.36% -112.82% | 49.61% +1,039.93% | -5.28% -140.62% | |
Current Ratio | 3.55 +16.68% | 3.04 +6.55% | 2.86 +25.74% | 2.27 +0.76% | |
Cash Ratio | 0.72 +14.24% | 0.63 -28.83% | 0.88 +49.66% | 0.59 -17.96% | |
Debt-to-Equity Ratio | N/A N/A | 0.20 -17.87% | 0.24 -13.99% | 0.28 +5.68% | |
Debt-to-Assets Ratio | N/A N/A | 0.14 +3.89% | 0.14 -8.84% | 0.15 +2.19% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow